Skip to main content
HPB : The Official Journal of the International Hepato Pancreato Biliary Association logoLink to HPB : The Official Journal of the International Hepato Pancreato Biliary Association
. 2007;9(5):357–362. doi: 10.1080/13651820701646222

Microwave ablation in a hepatic porcine model: correlation of CT and histopathologic findings

Michael M Awad 1, Lara Devgan 1, Ihab R Kamel 2, Michael Torbensen 3, Michael A Choti 1,
PMCID: PMC2225513  PMID: 18345319

Abstract

Background. Thermal ablative techniques have gained increasing popularity in recent years as safe and effective options for patients with unresectable solid malignancies. Microwave ablation has emerged as a relatively new technique with the promise of larger and faster burns without some of the limitations of radiofrequency ablation (RFA). Here we study a new microwave ablation device in a living porcine model using gross, histologic, and radiographic analysis. Materials and methods. The size and shape of ablated lesions were assessed using six pigs in a non-survival study. Liver tissue was ablated using 2, 4, and 8 min burns, in both peripheral and central locations, with and without vascular inflow occlusion. To characterize the post-ablation appearance, three additional pigs underwent several 4 min ablations each followed by serial computed tomography (CT) imaging at 7, 14, and 28 days postoperatively. Results. The 2 and 4 min ablations resulted in lesions that were similar in size, 33.5 cm3 and 37.5 cm3, respectively. Ablations lasting 8 min produced lesions that were significantly larger, 92.0 cm3 on average. Proximity to hepatic vasculature and inflow occlusion did not significantly change lesion size or shape. In follow-up studies, CT imaging showed a gradual reduction in lesion volume over 28 days to 25–50% of the original volume. Discussion. Microwave ablation with a novel device results in consistently sized and shaped lesions. Importantly, we did not observe any significant heat-sink effect using this device, a major difference from RFA techniques. This system offers a viable alternative for creating fast, large ablation volumes for treatment in liver cancer.

Keywords: microwave, thermal, ablation, liver, porcine, hepatocellular, metastatic, cancer

Introduction

In recent years there has been a growing interest in interstitial ablative approaches for the treatment of unresectable tumors in the liver and other solid organs. In addition to increasing the number of patients eligible for potentially curative therapy, local tissue ablation is often performed with lower morbidity than resection. Moreover, it can be employed using both percutaneous and laparoscopic minimally invasive approaches as well as with open surgery.

A variety of methods have been used to locally ablate tissue. Thermal ablation using radiofrequency ablation (RFA) is currently the most frequently used modality 1,2,3. However, high local recurrence rates have been reported in patients treated with RFA, particularly for lesions >3.0 cm in diameter 3,4,5,6,7,8,9. RFA is also potentially limited by the heat-sink effect of nearby vessels resulting in incomplete tumor ablation 10,11,12. The rate of heating during RFA can be slow compared with other techniques. In addition, the zone of active heating created by RFA is typically small, often requiring multiple overlapping zones to achieve a larger ablation lesion. As a result, RFA procedure times can be prohibitively long.

Microwave ablation, an alternative method of thermal ablation, offers many of the advantages of RFA and has several other theoretical advantages that may increase its effectiveness in tumor killing 13. One limitation of traditional microwave ablation therapy has been the inability to treat large tumors without numerous overlapping ablations 14. Recent advances in the engineering of the microwave antennas using ceramic probes have succeeded in improving the speed and size of the ablation 15. The Microsulis Tissue Ablation (MTA) system (Microsulis Ltd, Edinburgh, UK) is a new microwave ablation device with the potential for larger, faster, and potentially more accurate burns 15. Most studies of this device report on short-term performance in ex vivo models. Therefore, we elected to study this device in a more realistic clinically relevant setting in an in vivo porcine model. A variety of clinically relevant parameters were evaluated, including the power, time, and ablation volume relationship; effects of ablation location and inflow occlusion; and short-term follow-up to characterize the post-ablation appearance on serial CT imaging.

Materials and methods

Microwave ablation

The Microsulis Tissue Ablation (MTA) system was used for all experiments. The MTA employs a 2.45 GHz, 100 W microwave device with an active 5.7 mm diameter radiator, powered by a magnetron generator. A microwave detector was used to ensure safe exposure of microwave energy to all personnel.

Animals

Swine weighing 40–60 lb were used in the study. All animals were treated in accordance with Johns Hopkins University Animal Care and Use Committee protocols.

Non-survival studies

Animals underwent general anesthesia and an open laparotomy was performed. The microwave ablation applicator probe was inserted into the liver parenchyma utilizing ultrasound guidance to optimize and characterize position relative to major vascular structures. To determine the effect of ablation time on the size and shape of lesions, ablations were performed using 100 W of power for 2, 4, or 8 min durations. These parameters were chosen on the basis of established heating curve data in liver for the MTA system 15.

One limitation of RFA techniques is the inability to achieve consistently shaped burns when near vasculature, known as the ‘heat-sink effect.’ To evaluate this in our study, we compared the shape and size of ablation lesions when the probe was placed peripherally in liver or centrally, in proximity to major vasculature. Central ablations were conducted with probe placement under ultrasound guidance within 1 cm of the origin of a major hepatic vein. To further characterize the effect of adjacent blood flow, both central and peripheral lesions were compared with and without temporary total in-flow occlusion. This was done with the application of a non-crushing clamp on the porta hepatis during the ablation period.

Hemodynamic monitoring was performed throughout each ablation, and the amount of bleeding upon withdrawal of the applicator probe was also recorded. Pigs were euthanized immediately following ablation procedures.

Survival studies

The purpose of this series of experiments was to determine the change in size and shape of ablated lesions in living pigs over time and to correlate these changes with radiologic and histopathologic data. In three pigs, lesions were created in peripheral liver parenchyma without inflow occlusion. In each animal, two or three 100W 8 min ablations were performed. These pigs were recovered from surgery and underwent CT imaging at 7, 14, and 28 day intervals. Following the last imaging, animals were euthanized, livers were harvested, and ablated lesions were measured grossly as well as cross-sectioned and examined microscopically using vital staining.

Liver evaluation

The livers were harvested en bloc and sliced at 3 mm intervals. Lesion size was measured in the short axis and long axis in relation to the applicator probe. Lesion volume is calculated as 4/3π(short axis/2)2(long axis/2). Portions of these liver samples were then fixed in 10% formalin, mounted in paraffin blocks, sliced at a thickness of 10 µm, and stained with hematoxylin and eosin (H&E). Slices were imaged on an optical scanner and saved as electronic files.

Ablation volume and shape determination

Radiologic studies were conducted by a radiologist (I.R.K.) blinded to the treatment group and time. Image processing was performed using a commercially available Advantage Windows workstation (General Electric Medical Systems, Milwaukee, WI, USA). Measurement of liver volume was performed by hand tracing the tumor contour on the axial portal venous phase images as described in prior studies 16,17. Hand tracing was performed on every axial image to enhance accuracy in volumetric measurements. A three-dimensional model of the liver and tumor was generated.

Statistical analysis

The student's t test was used for all analyses. A p<0.05 level was used to determine statistical significance.

Results

Safety and performance studies

The 100 W ablations of varying duration (2, 4, and 8 min) resulted in consistent and grossly evident ablations (Figure 1). Lesions were roughly ellipsoid in shape, becoming more spherical with longer ablation time. Table I summarizes the short-axis and long-axis diameters as well as the total ablation volume. Ablations lasting 2 min resulted in lesions that had an average volume of 33.5 cm3 (short-axis diameter = 3.7 cm). Ablations lasting 4 min were not statistically larger, with an average volume of 37.5 cm3 and average short-axis diameter of 3.8 cm. At 8 min, ablation lesions were significantly larger, with the short axis diameter averaging 5.3 cm and the average volume averaging 92.0 cm3.

Figure 1. .

Figure 1. 

Gross section of 100 W, 4 min ablation from freshly harvested pig liver. Microwave ablation applicator probe is shown in situ for reference (each line on the probe represents 1 cm). A large portal venous branch is shown near the probe tip (black arrow). No heat sink effect is apparent. Histology from the transition zone (white box) is shown in Figure 2.

Table I. Size of lesions by ablation duration.

Ablation duration (min) Short axis (cm) Long axis (cm) Volume (cm3)
2 3.7±0.6 4.5±0.9 33.5±17.3
4 3.8±0.5 4.9±0.5 37.5±12.8
8 5.3±0.6* 6.4±1.1 92.0±6.5*

In these studies, all ablations were performed at 100 W in peripheral locations without inflow occlusion. Lesion lengths and volumes are given as mean±one standard deviation. n=3 for each experiment.

*p<0.05.

Histologic assessment of the areas of ablation confirmed complete necrosis in the entire regions seen and measured on gross examination. Moreover, a sharp transition zone was identified between ablated tissue and normal appearing liver parenchyma correlating with the gross assessment (Figure 2).

Figure 2. .

Figure 2. 

Histology of transition zone at margin of ablated lesion (inset from Figure 1). At the top of the image is necrotic tissue; normal hepatic parenchyma is at the bottom. The transition zone in the center of the image reveals infiltration of erythrocytes, leukocytes, and disruption of the normal hepatic architecture. H&E, ×20.

There were no identifiable problems or complications during the liver ablation in the animals. They remained hemodynamically stable throughout the procedures and bleeding was not problematic either during ablation or upon removal of the probes.

Impact of location and inflow occlusion on ablation characteristics

The results of the ablation location and inflow occlusion studies are shown in Table II. Applications of 100 W lasting 4 min were used for all ablations during this experiment. Lesions created in the peripheral liver without inflow occlusion were, on average, 3.8 cm×4.9 cm and 37.5 cm3 in size. Application of inflow occlusion in comparable peripheral lesions resulted in increased size, averaging 4.4 cm×6.1 cm and 64.5 cm3 in size. Ablation in perivascular central sites resulted in zones of comparable size and shape to peripheral sites, averaging 3.8 cm×5.3 cm (volume 44.8 cm3). When inflow occlusion was applied to central ablation sites, lesion size averaged 4.5 cm×6.6 cm (volume 68.9 cm3), not statistically different. Differences in the shape of ablation zones were difficult to quantify. In all cases, regardless of proximity to major vascular structures and application of inflow occlusion, no evident differences were observed in the subjective appearance of the shape, nor the relationship between short-axis and long-axis diameters. Specifically, parenchymal viability did not appear to be preserved immediately adjacent to major vascular structures and no shape alteration was observed near these structures.

Table II. Size of ablated lesions from vital structure and heat-sink study.

Ablation site Inflow occlusion Short axis (cm) Long axis (cm) Volume (cm3)
Peripheral No 3.8±0.5 4.9±0.5 37.5±12.8
Peripheral Yes 4.4±0.9 6.1±0.1* 64.5±24.2
Central No 3.8±1.2 5.3±0.8 44.8±26.3
Central Yes 4.5±0.1 6.6±0.3 68.9±2.8

All ablations were performed at 100 W for 4 min each. Lesion lengths and volumes are given as mean±one standard deviation. Volume is calculated as 4/3π(short axis)2(long axis). n=3 for each experiment.

*p<0.05.

Post-ablation CT of microwave lesions

CT appearance of regions of microwave ablation revealed areas of hypodensity and lack of perfusion (Figure 3). This appearance is similar to that seen with other methods of thermal ablation. Imaging of ablation regions at day 7 correlated with the initial ablation shape and volume of 4 min at 100 W found in our earlier studies. Serial CT imaging at day 14 and 28 revealed a consistent volume contraction over time (Figures 3 and 4, Table III). In seven of eight cases, the lesion volume on day 28 was 25–50% of that on day 7. In one case, the post-ablation site appeared larger on day 14, decreasing by day 28 to only 77% of the initial size. A Hounsfield unit analysis of this lesion suggested that this size increase was likely due to a bleed around this lesion.

Figure 3. .

Figure 3. 

CT imaging demonstrating contraction of lesion over time. The same lesion (white arrows) in a single pig imaged on postoperative days 7, 14, and 28 is shown.

Figure 4. .

Figure 4. 

Survival study CT data showing changes in lesion volume over time. Average volume of ablated lesions on postoperative days 7, 14, and 28 based on CT imaging calculations. Horizontal lines indicate the averages (n=8) for each postoperative day with value labeled next to each line.

Table III. Dimensions and volumes of lesions from CT imaging at postoperative days 7, 14, and 28.

Parameter Day 7 CT data Day 14 CT data Day 28 CT data Day 28 Gross data
Length (cm) 5.5±0.7 4.9±0.7 3.9±0.8 3.7±0.4
Height (cm) 3.3±0.35 3.1±0.5 2.3±0.5 2.3±0.7
Volume (cm3) 31.5±8.9 25.9±10.3 11.5±5.8 11.7±6.2

Gross specimen size at day 28 is also shown for comparison. Numbers are given as means±standard deviation. n=8 for all experiments.

Following the final CT imaging, the ablation sites were analyzed grossly for size and shape. Lesion sizes and volumes as measured by CT imaging and as measured by direct measurement of gross specimens were nearly identical (Table III, columns three and four). As seen in the initial studies, CT assessment and day 28 gross evaluation of the ablation sites did not appear to be affected by a heat-sink effect. Symmetric ellipsoid lesions were seen even in close proximity to hepatic vasculature. Vessels remain patent as evidenced by contrast enhancement.

Discussion

These data demonstrate that microwave ablation utilizing a single application of this high energy single probe device can result in reproducible and predictable large volume lesions in living liver tissue in little time. Lesion size can be increased by application of energy for longer duration, particularly beyond 4 min. A single 100 W probe application for 8 min resulted in lesions consistently >5 cm. This would typically represent the upper limit for most commercially available RF devices using considerably longer application times 18.

Based on these results, it appears that thermal ablation using this microwave device is unaffected by high blood flow in proximity its application. Specifically, ablation regions appeared to be of consistent size and symmetric shape, independent of the location near vascular structures. If validated in clinical studies, this feature may prove to be particularly advantageous over other ablation methods such as RFA. Several mechanisms have been postulated as to why microwave ablation devices resist heat-sink effects 19. Unlike RFA, which relies largely on conductive dissipation of heat, microwave energy is delivered to a greater distance from the source, relying less on conductive heat transmission.

The gradual reduction in ablated lesion size over time was also notable. Lesions consistently underwent concentric contraction over the 4 week period of this study. Histologic analysis reveals that the necrotic liver tissue is gradually replaced by regenerative hepatic parenchyma. This is not unique to microwave ablation and has been well described in the literature with most other ablative techniques including RF, cryoablation, and HIFU (high intensity focused ultrasound) 20.

CT was a useful modality for monitoring change in lesion size/shape over time. On average, CT measurements differed from gross lesion measurement by only 4 mm. Nevertheless, this level of accuracy may be insufficient for clinical purposes given that some neoplastic lesions that are the targets of ablative therapies are only 1 cm in size. MRI has often been used in the immediate and postoperative monitoring of hepatic ablation techniques and may prove beneficial in monitoring post-microwave ablative therapies 21.

Compared with RFA, microwave ablation has a wider zone of active heating. In some reports this can be up to 6 cm surrounding the antenna 15,22,23,24. This may allow more uniform tumor killing both within a targeted area and next to vasculature. Unlike RF energy, microwave energy does not appear to be limited by charring and tissue desiccation 14. In addition, the time of ablation may be faster, multiple simultaneous probes can be used, and no return electrodes are necessary that can lead to inadvertent skin burns 14,25,26,27. Finally, the size and shape of the zone of ablation may be more consistent and less dependent on heat sinks from vascular structures in proximity 25,28,29.

Several limitations are notable in this study. First, while the length of ablation time was varied in these experiments, a constant ablation power (100 W) was used. More recent microwave devices in development can deliver power of 150 W or greater. Other power settings may result in different ablation characteristics. Second, non-tumor-bearing tissue was used in these studies. Further studies will help to better elucidate the effects of this new microwave ablation probe and its safety in preclinical and clinical settings.

Acknowledgements and disclosures

The authors would like to thank P. Randall Brown for assistance with animal care and handling. Funding for this study was made possible by a grant from Microsulis Ltd.

References

  • 1.Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities – part II. J Vasc Interv Radiol. 2001;12:1135–48. doi: 10.1016/s1051-0443(07)61670-4. [DOI] [PubMed] [Google Scholar]
  • 2.Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer. 2005;103:1201–9. doi: 10.1002/cncr.20892. [DOI] [PubMed] [Google Scholar]
  • 3.Sutherland LM, Williams JA, Padbury RT, Gotley DC, Stokes B, Maddern GJ. Radiofrequency ablation of liver tumors: a systematic review. Arch Surg. 2006;141:181–90. doi: 10.1001/archsurg.141.2.181. [DOI] [PubMed] [Google Scholar]
  • 4.Lu DS, Yu NC, Raman SS, Limanond P, Lassman C, Murray K, et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology. 2005;234:954–60. doi: 10.1148/radiol.2343040153. [DOI] [PubMed] [Google Scholar]
  • 5.Amersi FF, McElrath-Garza A, Ahmad A, Zogakis T, Allegra DP, Krasne R, et al. Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg 2006;141:581–7; discussion 587–8. [DOI] [PubMed] [Google Scholar]
  • 6.Machi J, Bueno RS, Wong LL. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J Surg. 2005;29:1364–73. doi: 10.1007/s00268-005-7829-6. [DOI] [PubMed] [Google Scholar]
  • 7.Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. 2001;221:159–66. doi: 10.1148/radiol.2211001624. [DOI] [PubMed] [Google Scholar]
  • 8.van Duijnhoven FH, Jansen MC, Junggeburt JM, van Hillegersberg R, Rijken AM, van Coevorden F, et al. Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol. 2006;13:651–8. doi: 10.1245/ASO.2006.08.014. [DOI] [PubMed] [Google Scholar]
  • 9.Aloia TA, Vauthey JN, Loyer EM, Ribero D, Pawlik TM, Wei SH, et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 2006;141:460–6; discussion 466–7. [DOI] [PubMed] [Google Scholar]
  • 10.Goldberg SN, Hahn PF, Tanabe KK, Mueller PR, Schima W, Athanasoulis CA, et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol. 1998;9(1 Pt 1):101–11. doi: 10.1016/s1051-0443(98)70491-9. [DOI] [PubMed] [Google Scholar]
  • 11.Steinke K, Haghighi KS, Wulf S, Morris DL. Effect of vessel diameter on the creation of ovine lung radiofrequency lesions in vivo: preliminary results. J Surg Res. 2005;124:85–91. doi: 10.1016/j.jss.2004.09.008. [DOI] [PubMed] [Google Scholar]
  • 12.Kim SK, Rhim H, Kim YS, Koh BH, Cho OK, Seo HS, et al. Radiofrequency thermal ablation of hepatic tumors: pitfalls and challenges. Abdom Imaging. 2005;30:727–33. doi: 10.1007/s00261-005-0304-x. [DOI] [PubMed] [Google Scholar]
  • 13.Fahy BN, Jarnagin WR. Evolving techniques in the treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, microwave coagulation, hepatic arterial chemotherapy, indications and contraindications for resection, role of transplantation, and timing of chemotherapy. Surg Clin North Am. 2006;86:1005–22. doi: 10.1016/j.suc.2006.06.003. [DOI] [PubMed] [Google Scholar]
  • 14.Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005;25(Suppl 1):S69–S83. doi: 10.1148/rg.25si055501. [DOI] [PubMed] [Google Scholar]
  • 15.Hines-Peralta AU, Pirani N, Clegg P, Cronin N, Ryan TP, Liu Z, et al. Microwave ablation: results with a 2.45-GHz applicator in ex vivo bovine and in vivo porcine liver. Radiology. 2006;239:94–102. doi: 10.1148/radiol.2383050262. [DOI] [PubMed] [Google Scholar]
  • 16.Kamel IR, Erbay N, Warmbrand G, Kruskal JB, Pomfret EA, Raptopoulos V. Liver regeneration after living adult right lobe transplantation. Abdom Imaging. 2003;28:53–7. doi: 10.1007/s00261-001-0192-7. [DOI] [PubMed] [Google Scholar]
  • 17.Kamel IR, Kruskal JB, Warmbrand G, Goldberg SN, Pomfret EA, Raptopoulos V. Accuracy of volumetric measurements after virtual right hepatectomy in potential donors undergoing living adult liver transplantation. AJR Am J Roentgenol. 2001;176:483–7. doi: 10.2214/ajr.176.2.1760483. [DOI] [PubMed] [Google Scholar]
  • 18.Gillams AR. The use of radiofrequency in cancer. Br J Cancer. 2005;92:1825–9. doi: 10.1038/sj.bjc.6602582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Haemmerich D, Laeseke PF. Thermal tumour ablation: devices, clinical applications and future directions. Int J Hyperthermia. 2005;21:755–60. doi: 10.1080/02656730500226423. [DOI] [PubMed] [Google Scholar]
  • 20.Weber SM, Lee FT., Jr Expanded treatment of hepatic tumors with radiofrequency ablation and cryoablation. Oncology (Williston Park) 2005;19(11 Suppl 4):27–32. [PubMed] [Google Scholar]
  • 21.Guan YS, Sun L, Zhou XP, Li X, Zheng XH. Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up. World J Gastroenterol. 2004;10:3543–8. doi: 10.3748/wjg.v10.i24.3543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Strickland AD, Clegg PJ, Cronin NJ, Elabassy M, Lloyd DM. Rapid microwave ablation of large hepatocellular carcinoma in a high-risk patient. Asian J Surg. 2005;28:151–3. doi: 10.1016/s1015-9584(09)60282-7. [DOI] [PubMed] [Google Scholar]
  • 23.Strickland AD, Clegg PJ, Cronin NJ, Swift B, Festing M, West KP, et al. Experimental study of large-volume microwave ablation in the liver. Br J Surg. 2002;89:1003–7. doi: 10.1046/j.1365-2168.2002.02155.x. [DOI] [PubMed] [Google Scholar]
  • 24.Swift B, Strickland A, West K, Clegg P, Cronin N, Lloyd D. The histological features of microwave coagulation therapy: an assessment of a new applicator design. Int J Exp Pathol. 2003;84:17–30. doi: 10.1046/j.1365-2613.2003.00236.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Wright AS, Lee FT, Jr, Mahvi DM. Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol. 2003;10:275–83. doi: 10.1245/aso.2003.03.045. [DOI] [PubMed] [Google Scholar]
  • 26.Yu NC, Lu DS, Raman SS, Dupuy DE, Simon CJ, Lassman C, et al. Hepatocellular carcinoma: microwave ablation with multiple straight and loop antenna clusters – pilot comparison with pathologic findings. Radiology. 2006;239:269–75. doi: 10.1148/radiol.2383041592. [DOI] [PubMed] [Google Scholar]
  • 27.Meredith K, Lee F, Henry MB, Warner T, Mahvi D. Microwave ablation of hepatic tumors using dual-loop probes: results of a phase I clinical trial. J Gastrointest Surg. 2005;9:1354–60. doi: 10.1016/j.gassur.2005.07.028. [DOI] [PubMed] [Google Scholar]
  • 28.Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee FT., Jr Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology. 2005;236:132–9. doi: 10.1148/radiol.2361031249. [DOI] [PubMed] [Google Scholar]
  • 29.Midorikawa T, Kikuchi H, Ishibashi K, Saito M, Hatakeyama T, Kadokura S, et al. Microwave coagulation therapy for a liver tumor involving the root of the left hepatic vein of the residual liver after extended right hepatectomy. Hepatogastroenterology. 2004;51:1148–50. [PubMed] [Google Scholar]

Articles from HPB : The Official Journal of the International Hepato Pancreato Biliary Association are provided here courtesy of Elsevier

RESOURCES